Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 35 Records) |
Query Trace: Neutropenia and MTHFR[original query] |
---|
Methylene tetrahydrofolate reductase gene polymorphism in Egyptian children with acute lymphoblastic leukemia. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2010 Jan 21 (1): 28-34. Tantawy Azza A G, El-Bostany Eman A, Adly Amira A M, Abou El Asrar Mohammed, El-Ghouroury Eman A, Abdulghaffar Esmat |
Prediction of irinotecan and 5-fluorouracil toxicity and response in patients with advanced colorectal cancer. The pharmacogenomics journal 2011 Feb 11 (1): 61-71. Glimelius B, Garmo H, Berglund A, Fredriksson L A, Berglund M, Kohnke H, Byström P, Sørbye H, Wadelius |
Study of the pharmacokinetic and pharmacogenetic contribution to the toxicity of high-dose methotrexate in children with acute lymphoblastic leukemia. Medical oncology (Northwood, London, England) 2012 Sep 29 (3): 2053-62. El-Khodary Noha M, El-Haggar Sahar M, Eid Manal A, Ebeid Emad |
Effects of methylenetetrahydrofolate reductase gene polymorphisms on toxicities during consolidation therapy in pediatric acute lymphoblastic leukemia in a Chinese population. Leukemia & lymphoma 2011 Jun 52 (6): 1030-40. Liu Shu-Guang, Li Zhi-Gang, Cui Lei, Gao Chao, Li Wei-Jing, Zhao Xiao- |
Phase II trial of pemetrexed and bevacizumab in patients with recurrent or metastatic head and neck cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 Mar 29 (9): 1140-5. Argiris Athanassios, Karamouzis Michalis V, Gooding William E, Branstetter Barton F, Zhong Shilong, Raez Luis E, Savvides Panayiotis, Romkes Marjor |
MTHFR polymorphisms and capecitabine-induced toxicity in patients with metastatic colorectal cancer. Pharmacogenetics and genomics 2013 Apr 23 (4): 208-18. van Huis-Tanja Lieke H, Gelderblom Hans, Punt Cornelis J A, Guchelaar Henk-J |
Pharmacogenetic analysis of adjuvant FOLFOX for Korean patients with colon cancer. Cancer chemotherapy and pharmacology 2013 Jan . Lee KH, Chang HJ, Han SW, Oh DY, Im SA, Bang YJ, Kim SY, Lee KW, Kim JH, Hong YS, Kim TW, Park YS, Kang WK, Shin SJ, Ahn JB, Kang GH, Jeong SY, Park KJ, Park JG, Kim TY |
Pharmacogenetic studies in children with acute lymphoblastic leukemia in Argentina. Leukemia & lymphoma 2015 May 56 (5): 1370-8. Aráoz Hilda Verónica, D'Aloi Karina, Foncuberta María Eugenia, Sanchez La Rosa Christian Germán, Alonso Cristina Noemí, Chertkoff Lilien, Felice Mari |
Role of folate status and methylenetetrahydrofolate reductase genotype on the toxicity and outcome of induction chemotherapy in children with acute lymphoblastic leukemia. Leukemia & lymphoma 2015 May 56 (5): 1379-84. Roy Moulik Nirmalya, Kumar Archana, Agrawal Suraksha, Awasthi Shally, Mahdi Abbas Ali, Kumar Ashuto |
Genetic polymorphisms in candidate genes predict increased toxicity with methotrexate therapy in Lebanese children with acute lymphoblastic leukemia. Pharmacogenetics and genomics 2014 Aug 24 (8): 387-96. Zgheib Nathalie K, Akra-Ismail Maya, Aridi Carol, Mahfouz Rami, Abboud Miguel R, Solh Hassan, Muwakkit Samar |
Genetic markers for toxicity of adjuvant oxaliplatin and fluoropyrimidines in the phase III TOSCA trial in high-risk colon cancer patients. Scientific reports 2014 4 6828. Ruzzo Annamaria, Graziano Francesco, Galli Fabio, Giacomini Elisa, Floriani Irene, Galli Francesca, Rulli Eliana, Lonardi Sara, Ronzoni Monica, Massidda Bruno, Zagonel Vittorina, Pella Nicoletta, Mucciarini Claudia, Labianca Roberto, Ionta Maria Teresa, Veltri Enzo, Sozzi Pietro, Barni Sandro, Ricci Vincenzo, Foltran Luisa, Nicolini Mario, Biondi Edoardo, Bramati Annalisa, Turci Daniele, Lazzarelli Silvia, Verusio Claudio, Bergamo Francesca, Sobrero Alberto, Frontini Luciano, Magnani Mau |
Germline TYMS genotype is highly predictive in patients with metastatic gastrointestinal malignancies receiving capecitabine-based chemotherapy. Cancer chemotherapy and pharmacology 2015 Apr 75 (4): 763-72. Joerger M, Huitema A D R, Boot H, Cats A, Doodeman V D, Smits P H M, Vainchtein L, Rosing H, Meijerman I, Zueger M, Meulendijks D, Cerny T D, Beijnen J H, Schellens J H |
Effect of folate status and methylenetetrahydrofolate reductase genotypes on the complications and outcome of high dose methotrexate chemotherapy in north Indian children with acute lymphoblastic leukemia. Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology 0 37 (2): 85-9. Moulik Nirmalya Roy, Kumar Archana, Agrawal Suraksha, Mahdi Abbas Ali, Kumar Ashuto |
Bevacizumab combined with docetaxel, oxaliplatin, and capecitabine, followed by maintenance with capecitabine and bevacizumab, as first-line treatment of patients with advanced HER2-negative gastric cancer: A multicenter phase 2 study. Cancer 2016 Mar . Meulendijks Didier, de Groot Jan Willem B, Los Maartje, Boers James E, Beerepoot Laurens V, Polee Marco B, Beeker Aart, Portielje Johanna E A, Goey Swan H, de Jong Robert S, Vanhoutvin Steven A L W, Kuiper Maria, Sikorska Karolina, Pluim Dick, Beijnen Jos H, Schellens Jan H M, Grootscholten Cecile, Tesselaar Margot E T, Cats Annemie |
Influence of chemotherapeutic drug-related gene polymorphisms on toxicity and survival of early breast cancer patients receiving adjuvant chemotherapy. BMC cancer 2017 Jul 17 (1): 502. Ludovini Vienna, Antognelli Cinzia, Rulli Antonio, Foglietta Jennifer, Pistola Lorenza, Eliana Rulli, Floriani Irene, Nocentini Giuseppe, Tofanetti Francesca Romana, Piattoni Simonetta, Minenza Elisa, Talesa Vincenzo Nicola, Sidoni Angelo, Tonato Maurizio, Crinò Lucio, Gori Stefan |
Correlation Between Methylenetetrahydrofolate Reductase (MTHFR) C677T Polymorphisms and Pemetrexed Chemotherapy Efficacy/Toxicity in Non-Squamous Non-Small Cell Lung Cancer. Medical science monitor : international medical journal of experimental and clinical research 2017 Nov 23 5683-5689. Lan Gaochen, Lin Lin, Chen Xiong, Chen Libin, Chen |
DPYD*2A and MTHFR C677T predict toxicity and efficacy, respectively, in patients on chemotherapy with 5-fluorouracil for colorectal cancer. Cancer chemotherapy and pharmacology 2017 Nov . Nahid Noor Ahmed, Apu Mohd Nazmul Hasan, Islam Md Reazul, Shabnaz Samia, Chowdhury Surid Mohammad, Ahmed Maizbha Uddin, Nahar Zabun, Islam Md Siddiqul, Islam Mohammad Safiqul, Hasnat Ab |
Study of gene polymorphisms as predictors of treatment efficacy and toxicity in patients with indolent non-hodgkin lymphomas and mantle cell lymphoma receiving bendamustine and rituximab. British journal of haematology 2018 Sep . Cencini Emanuele, Sicuranza Anna, Fabbri Alberto, Ferrigno Ilaria, Rigacci Luigi, Cox Maria C, Raspadori Donatella, Bocchia Moni |
Pathway genes and metabolites in thiopurine therapy in Korean children with acute lymphoblastic leukaemia. British journal of clinical pharmacology 2019 Mar . Choi Rihwa, Sohn Insuk, Kim Min-Ji, Woo Hye In, Lee Ji Won, Ma Youngeun, Yi Eun Sang, Koo Hong Hoe, Lee Soo-Yo |
Folate pathway genetic polymorphisms modulate methotrexate-induced toxicity in childhood acute lymphoblastic leukemia. Cancer chemotherapy and pharmacology 2019 Jan . Yousef Al-Motassem, Farhad Rand, Alshamaseen Daniah, Alsheikh Abrar, Zawiah Mohammed, Kadi Ta |
Association of C677T and A1298C MTHFR Polymorphisms and Fluoropyrimidine-induced Toxicity in Mestizo Patients With Metastatic Colorectal Cancer. Anticancer research 2020 Aug 40 (8): 4263-4270. Ramos-Esquivel Allan, Chinchilla Ricardo, Valle Mar |
Gene-Gene Interactions of Gemcitabine Metabolizing-Enzyme Genes hCNT3 and WEE1 for Preventing Severe Gemcitabine-Induced Hematological Toxicity. Journal of clinical pharmacology 2021 5 61 (10): 1376-1385. Li Juan, Chen Bing, Xi Wen-Qi, Yang Chen, Zhang Wei-X |
Genetic polymorphism in ATIC is associated with effectiveness and toxicity of pemetrexed in non-small-cell lung cancer. Thorax 2021 Apr . Visser Sabine, Koolen Stijn, van Donk Nadine, van Walree Nico, van der Leest Cor, Cornelissen Robin, van Schaik Ron, Mathijssen Ron, Aerts Joachim, Stricker Bruno |
Pharmacogenomics and functional imaging to predict irinotecan pharmacokinetics and pharmacodynamics: the predict IR study. Cancer chemotherapy and pharmacology 2021 Mar . Michael Michael, Liauw Winston, McLachlan Sue-Anne, Link Emma, Matera Annetta, Thompson Michael, Jefford Michael, Hicks Rod J, Cullinane Carleen, Hatzimihalis Athena, Campbell Ian G, Rowley Simone, Beale Phillip J, Karapetis Christos S, Price Timothy, Burge Mathew |
Study on Relationships of Tumor Status and Gene Polymorphism With Blood Concentration of MTX and Toxicities in 63 Pediatric Mature B Cell Lymphoma in Chinese Population. Technology in cancer research & treatment 0 20 1533033821995288. Huang Shuang, Jin Lin, Yang Jing, Duan Long Yan, Zhang Meng, Zhou Ju Chun, Zhang Hong Yo |
MTHFR polymorphism as a predictive biomarker for gastrointestinal and hematological toxicity in North Indian adenocarcinoma patients. Journal of chemotherapy (Florence, Italy) 2021 11 34 (5): 326-340. Walia Harleen Kaur, Singh Navneet, Sharma Siddhar |
Effects of polymorphisms in the MTHFR gene on 5-FU hematological toxicity and efficacy in Thai colorectal cancer patients. Frontiers in oncology 2022 12 916650. Atasilp Chalirmporn, Lenavat Rinradee, Vanwong Natchaya, Chansriwong Phichai, Sirachainan Ekaphop, Reungwetwattana Thanyanan, Jinda Pimonpan, Aiempradit Somthawin, Sirilerttrakul Suwannee, Chamnanphon Monpat, Puangpetch Apichaya, Sankuntaw Nipaporn, Satapornpong Patompong, Sukasem Chonlaph |
Personalized Medicine in Infant Population with Cancer: Pharmacogenetic Pilot Study of Polymorphisms Related to Toxicity and Response to Chemotherapy. Cancers 2023 3 15 (5): . Urtasun Andrea, Olivera Gladys G, Sendra Luis, Aliño Salvador F, Berlanga Pablo, Gargallo Pablo, Hervás David, Balaguer Julia, Juan-Ribelles Antonio, Andrés María Del Mar, Cañete Adela, Herrero María Jo |
Relationship between methylenetetrahydrofolate reductase gene polymorphisms and methotrexate drug metabolism and toxicity. Translational pediatrics 2023 2 12 (1): 31-45. Tan Yinli, Kong Qian, Li Xinyu, Tang Yanlai, Mai Huirong, Zhen Zijun, Zhou Dunhua, Chen Huiq |
Gene polymorphism and prediction of toxicity to platinum-based chemotherapy in patients with gynecologic cancer. Clinical and translational science 2023 11 . Xuan Huang, Junmin Li, Xiaoying Pang, Jialei Zhu, Jiaqian Pan, Yueyan Li, Jing Ta |
- Page last reviewed:Feb 1, 2024
- Content source: